EXORPHIA
Otemachi
About EXORPHIA
EXORPHIA is a biotechnology startup focused on creating innovative medicines through the use of extracellular vesicles. The company is involved in the research, development, production, and marketing of exosome-based drugs derived from human cells. EXORPHIA operates in two primary sectors: the Drug Discovery Business, which seeks to commercialize exosomes for pharmaceutical applications, and the Non-Drug Discovery Business, which markets exosomes as raw materials for non-medical products.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.4M
- Last round: Corporate Round (Aug 2025)
- Website: exorphia.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Manufacturing, Product Research
Social Profiles
Canonical: https://fsome.com/organization/exorphia-61773 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.